Tel: +44(0)20 7691 0984 Email: contact@transpharmation.co.uk Newsletter Sign Up
  • CEO Mark Duxon interviewed by The Pharma Letter on impact of Brexit on CROs...
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • State-of-the-art premises opening this month at Discovery Park in Kent...
  • Newly published work in Frontiers in Psychiatry demonstrating
  • the effectiveness of a clinically relevant dose of ketamine...
  • Head to 2021 conferences page to see titles of abstracts...
 

News

News you can use

IASP

IASP

Transpharmation Ltd are delighted to be one of the sponsors of the first virtual conference held by The International Association for the Study of Pain, (IASP). The event runs from 8th September 2020 to 31st March 2021. We’ll be showcasing our latest specialist poster; ‘The effect of a reduced streptozocin dose and social housing on well-being, mechanical hypersensitivity and burrowing behaviour in type 1 diabetic rodents’. Come and see us! #iaspvirtualseries https://www.eventscribe.com/2020/IASP-Virtual-Series-on-Pain/

 

 

 

Read More
293 Hits

WMS virtual conference 28th September – 2nd October 2020

final-logo-circular-medium

As experts in preclinical neuroscience, we look forward to attending the 25th annual international congress of the World Muscle Society and making contact with other participants. https://www.worldmusclesociety.org/web_pages/view/home Already involved in the EU-funded Brain Involvement in Dystrophinopathies, (BIND) project, our combined research aims at achieving ground-breaking progress in the understanding and treatment of neuropsychiatric comorbidities affecting Duchenne and Becker muscular dystrophy patients. For more information about our work in this particular field please email This email address is being protected from spambots. You need JavaScript enabled to view it.

Read More
201 Hits

BIND Project

image-for-website

We're pleased to share with you the newly launched website for the BIND project and we're delighted to be a part of the scientific team. https://bindproject.eu/ It's the first project of this scale to improve characterisation of brain involvement in Duchenne and Becker Muscular Dystrophy (DMD and BMD). This EU-funded project, connecting 19 partners from Europe and Japan, aims to address a crucial aspect of DMD and BMD that was already recognised in 1861, when Duchenne de Boulogne first described the neuromuscular condition. In the last few decades however, most of the efforts have focused on improving outcomes related to muscle weakness, whilst brain involvement has received less attention.

Read More
484 Hits

Congratulations to Transpharmation's Dr. Jack Prenderville

Jack_LindekIn_Profile_Photo

Congratulations to Dr. Jack Prenderville, Head of Research at Transpharmation's Irish site, on his nomination to the position of Adjunct Assistant Professor in the Department of Physiology at Trinity College Dublin. For a number of years Jack has made a valuable contribution to teaching and research, delivering neuropharmacology lectures and supervising undergraduate research students within the Department. This recognition is well deserved and adds an additional dimension to his role within Transpharmation.

Read More
470 Hits

New Parkinson's disease enterprise partnership with Trinity College Institute of Neuroscience

Tree-pic-for-Parkinsons-disease-news-page

We are pleased to announce an enterprise partnership with Professor Andrew Harkin, Trinity College Institute of neuroscience (TCIN) co-funded by Irish research Council (IRC) and Transpharmation Ltd. This partnership, initially supported for a four-year period, will establish a clinically relevant experimental platform to facilitate the development of new therapeutics for the treatment of Parkinson’s disease.

parkinson logos

Read More
743 Hits

Covid-19 update: April

covid-banner-april

During these unprecedented times, good communication and maintaining contact is more important than ever. That's why at Transpharmation we're making use of all the resources available for holding regular meetings with our clients to discuss ongoing and future projects. Although some of us are working from home and juggling family commitments, we remain close to you. We're all in this together and it's nice to stay in touch.

Contact me at any time: This email address is being protected from spambots. You need JavaScript enabled to view it.

Read More
688 Hits

Covid-19 update March

covid-banner-march

Business Continuation

Read More
651 Hits

Company of the year!

mark_companyoftheyear

Pharma Tech Outlook magazine have named Transpharmation ‘company of the year’ in their ‘top 5 UK CRO’s’ feature. We’re proud of this achievement on behalf of all the clients that we’ve worked with over the years and it’s a great start to our 10th anniversary year.

Read More
865 Hits

Transpharmation Ltd are one of the partners to receive the prestigious Horizon 2020 Grant

BIND_Logo_Rectangle-1

We are delighted to announce that Transpharmation Ltd is to be one of the partners enlisted in the EU-funded first international project to study dystrophin in the brain in Duchenne and Becker Muscular Dystrophy (DMD and BMD).

Read More
790 Hits

Advancing preclinical neuropathic pain research

uni_hert

A focus on sleep, depression and chemobrain in collaboration with the University of Hertfordshire.

For patients suffering with chronic neuropathic pain, (e.g. diabetes, chemotherapy) the need for suitable novel therapies is imperative. The key to developing new treatments lies in identifying measurable endpoints in both preclinical and human subjects to aid translation of preclinical results to the clinic.

Building on the impressive work that Transpharmation’s Dr Amy Fisher has already accomplished, we have partnered with Dr Lisa Lione's team at the University of Hertfordshire to successfully recruit multi award winning PhD student Michael Lanigan to focus exclusively on refining novel endpoints for our neuropathic pain assays. Michael was recently awarded the prestigious 2019 British Pharmacological Society Undergraduate Prize.

Using our strengths in EEG, MMN, cognition and biomarker analysis we will be working with UoH to better understand the behavioural and biochemical impact of pain and analgesia. We hope this work will create better translational preclinical research models, refine the drug discovery process for our clients and lead to the development of new medicines for patients suffering with neuropathic pain. If you would like to see our recent research in this area, please use this link to view the posters here View Posters

Read More
816 Hits

Trinity College Institute of Neuroscience Seminar Series 2019

Neuroscience-Seminar-Series-2019

On Monday 9th December, Transpharmation’s scientific expert Dr Sandor Kantor will be presenting his work on ''Altered EEG oscillations as correlates of abnormal brain function in neuropsychiatric diseases'' as part of the Trinity College Institute of Neuroscience Seminar Series 2019. For further information please contact our Dublin based science lead Jack Prenderville This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Read More
833 Hits

Don’t miss out!

splat_banner

Transpharmation Ltd are a global CRO, wherever you are, whatever language you speak, we’d be happy to work with you. If you have a project in mind, or simply wish to find out how we might be able to help you during 2020, please contact me at This email address is being protected from spambots. You need JavaScript enabled to view it. We have clients already scheduling work with us next year.

 

Read More
783 Hits

Have you downloaded our recent work?

pdf_banner

Transpharmation’s scientific team presented five posters at the recent SfN conference and interest in them was high. We’ve made all five available to view or download here on our website; simply complete a short application process by following this link - Register

 

Read More
710 Hits
 

Start a Conversation

uk flag +44 (0)20 7691 0984

ireland flag +353 (0)1896 42 60

poland flag +48 515 244 120

mail contact@transpharmation.co.uk


Copyright

Copyright © 2021 Transpharmation Ltd. All Rights Reserved.

Copyright © 2019 Transpharmation Ltd. All Rights Reserved. Website created by Identity Ipswich Web Design